Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001835701-22-000001
Filing Date
2022-02-07
Accepted
2022-02-07 16:36:47
Documents
1
Effectiveness Date
2022-02-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9693
  Complete submission text file 0001835701-22-000001.txt   10701
Mailing Address 161 HODGE ROAD PRINCETON NJ 08540
Business Address 161 HODGE ROAD PRINCETON NJ 08540 609-325-7701
Enalare Therapeutics Inc. (Filer) CIK: 0001835701 (see all company filings)

EIN.: 853032063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-432646 | Film No.: 22597902